Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Sinonasal undifferentiated carcinoma × enasidenib × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Chondrosarcoma 2 Sinonasal undifferentiated carcinoma 1 Immunoblastic Lymphadenopathy 1 Glioma 1 Esthesioneuroblastoma, Olfactory 1 Cholangiocarcinoma 1

Interventions

enasidenib 1 Radiotherapy, Intensity-Modulated 1 Protons 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06176989 2025-10-20

Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors

National Institutes of Health Clinical Center (CC)

Phase 2 Recruiting

Sinonasal undifferentiated carcinoma, Chondrosarcoma, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon ⚡